查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439270

疼痛管理設備 - 全球市場回顧、競爭格局、市場預測 (2030)

Pain Management Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球疼痛管理設備市場規模預計2023年將達到48.6億美元，2030年將達到76.7億美元，2024-2030年預測期間複合年增長率為7.90%。疼痛管理設備的需求主要由慢性疼痛盛行率上升、肌肉骨骼疾病高盛行率、人口老化迅速增加、人們對疼痛管理設備意識的快速提高以及創新產品的開發所推動。這是由研發投資增加和醫療保健成本上升推動的。

疼痛管理設備的市場動態

乳癌、肺癌和血癌等各種癌症的盛行率不斷上升，是疼痛管理設備市場的主要驅動因素。例如，根據世界衛生組織（WHO）（2022）的數據，2020年乳癌病例為226萬例，肺癌病例為221萬例，大腸癌病例為193萬例，攝護腺癌病例為141萬例，據報道，胃癌109萬例。神經性癌性疼痛 (NCP) 是由癌症本身引起的神經病變引起的，NCP 治療對許多癌症患者無效。引入更好的疼痛管理設備可以減輕癌症患者的疼痛。

骨關節炎、類風濕性關節炎等骨科疾病盛行率的上升也是疼痛管理設備市場的關鍵驅動因素。根據世界衛生組織（WHO）（2022）的數據，肌肉骨骼疾病是導致殘疾的主要原因，全球約有 17.1 億人患有骨質疏鬆症、骨關節炎和類風濕性關節炎等肌肉骨骼疾病。

根據世界衛生組織（2022）的數據，2019 年全球約有 5.28 億人患有骨關節炎。據同一消息來源稱，2019 年全球有 1800 萬人患有類風濕性關節炎。

骨關節炎，通常稱為退化性關節炎或磨料性關節炎，會影響關節並最終磨損骨骼表面的光滑軟骨。患者面臨嚴重的疼痛、水腫和關節炎症，這限制了他們的活動自由。這就是為什麼疼痛管理設備有助於治療疼痛。

老年患者數量的增加預計將改變醫療保健服務並增加對更好生活方式的需求。根據最近的一項研究 "Global Population Aging 2020 Report" （聯合國，2020），老年人口正以驚人的速度成長。2020年，全球65歲以上人口約為7.27億人。到 2050 年，此類患者的數量預計將增加一倍，達到 15 億。背痛、關節炎和慢性疼痛的病例隨著年齡的增長而增加。老年患者需要疼痛管理設備來改善他們的生活方式。因此，所有這些因素預計將推動疼痛管理設備市場的成長。

公司在研發上花費大量資金來開發和推出創新產品。2019 年1月，Boston Scientific宣布推出一款先進的慢性疼痛管理設備，該設備被證實是市場上為數不多的能夠結合麻木和亞感覺治療的設備之一。預計這將提高該產品的知名度並增加對疼痛管理設備的需求。

然而，也存在限制疼痛管理設備採用的因素，例如過敏反應和術後感染，以及缺乏使用疼痛管理設備的最佳實踐指南，這些因素也阻礙了疼痛的發展管理設備市場。馬蘇。

疼痛管理設備細分市場分析

就設備類型細分而言，神經調節和神經刺激設備預計將在疼痛管理設備市場中佔據最大份額。這種增長可能是由於神經系統疾病的盛行率不斷增加所致。

例如，根據癲癇中心2020年公佈的數據，全球約有5,000萬癲癇患者，每年約有240萬個新診斷病例。此外，根據世界衛生組織（WHO）（2023）的數據，全球約有 5,000 萬人患有失智症，每年新增近 1,000 萬例。其中約 60-70% 是阿茲海默氏型失智症。因此，需要採取緊急措施來減輕這項負擔。這些神經刺激裝置在治療慢性疼痛、帕金森氏症、癲癇、運動障礙和憂鬱症方面發揮重要作用。這是由於神經刺激裝置的成本效益、經皮神經電刺激（TENS）和脊髓刺激（SCS）裝置在緩解慢性疼痛方面的高效性以及發達國家SCS治療的報銷潛力。可能性。

本報告提供了全球疼痛管理設備市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第1章 疼痛管理設備市場報告簡介

第2章 疼痛管理設備市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第3章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章 疼痛管理設備市場關鍵因素分析

  • 疼痛管理設備市場驅動因素
    • 慢性疼痛的盛行率增加
    • 大眾對疼痛管理設備的認識迅速提高
    • 加大研發投入，開發創新產品
    • 創新產品發布
    • 醫療費用增加
  • 疼痛管理設備市場的限制與挑戰
    • 使用這些設備引起的過敏反應和術後感染限制了它們的採用。
    • 產品成本高
  • 疼痛管理設備市場機會
    • 新興經濟體尚未開發的潛力
    • 非醫院環境中對疼痛管理設備的需求不斷增長

第5章 疼痛管理裝置的波特五力分析

第6章 疼痛管理器材市場佈局

  • 按設備類型
    • 神經調節/神經刺激裝置
    • 止痛輸液泵
    • 消融裝置
    • 其他
  • 按用途
    • 神經性疼痛
    • 癌症痛
    • 臉部疼痛/偏頭痛
    • 肌肉骨骼疼痛
  • 按地區
    • 北美疼痛管理設備市場規模（2021-2030）
    • 歐洲疼痛管理設備市場規模（2021-2030）
    • 亞太地區疼痛管理設備市場規模（2021-2030）
    • 其他地區疼痛管理設備市場規模（2021-2030）

第7章：疼痛管理設備公司與產品簡介

  • Abbott Laboratories
  • Baxter International Inc.
  • Boston Scientific Corporation
  • B Braun Melsungen AG
  • Nevro Corp.
  • Colfax Corporation
  • Omron Corporation
  • Koninklijke Philips NV
  • Smiths Medical
  • Medtronic plc.
  • Stryker Corporation
  • Stimwave LLC
  • Kimberly Clark Corporation
  • DJO Global LLC.
  • Aleva neurotherapeutics SA

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第11章 關於 DelveInsight

第12章 免責聲明與聯絡我們

Product Code: DIMDCL0060

Pain Management Devices Market By Type Of Devices (Neuromodulation and Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices and Cryoablation Devices], and Others), Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), and Geography is expected to grow at a steady CAGR Forecast till 2030 owing to rise in prevalence of chronic pain and musculoskeletal disorders and surge in awareness among people toward pain management devices

The global pain management devices market was valued at USD 4.86 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 7.67 billion by 2030. The demand for Pain Management Devices is primarily motivated by the rise in the prevalence of chronic pain, the high prevalence of musculoskeletal disorders, the surge in the geriatric population, the surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and increasing cost of healthcare expenditure.

Pain Management Devices Market Dynamics:

The rising prevalence of different cancer types such as breast cancer, lung cancer, blood cancer, and others turns out to be an essential factor accelerating the pain management devices market. For instance, according to the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020. Neuropathic cancer pain (NCP) is caused by nerve damage attributable to cancer per se, and NCP management is ineffective in many cancer patients. With the introduction of better pain management devices, cancer patients may get relief from pain.

The rising prevalence of orthopedic diseases such as osteoarthritis, rheumatoid arthritis, and others is another important driver for the pain management devices market. According to World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

According to WHO 2022, worldwide around 528 million people suffered from osteoarthritis in 2019. As per the same source, worldwide 18 million people had rheumatoid arthritis in 2019.

Osteoarthritis often referred to as degenerative or wear-and-tear arthritis affects the joints and eventually causes the smooth cartilage on the surface of the bones to wear away. Patients face significant pain, edema, and joint inflammation which limits their ability to move freely. Pain management devices are thereby helpful to treat pain.

It is predicted that the rising number of elderly patients would transform healthcare delivery and create a larger demand for a better lifestyle. As per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure of such patients is expected to double and reach 1.5 billion by 2050. The cases of lower back pain, arthritis, and chronic pain increase with age. Older age patients require pain management devices to improve their living style. Thus, all these factors are projected to drive the growth of the market for pain management devices.

Companies are spending more on research and development for developing and launching innovative products. In January 2019, Boston Scientific announced the launch of an advanced chronic pain management device, which has been identified as one of the very few devices in the market with the ability to combine paresthesia and sub-perception therapy. This is expected to increase awareness about the product and boost the demand for pain management devices.

Certain factors such as hypersensitivity reactions and post-operative infections caused due to the use of these devices limit their adoption the pain management devices and also non-availability of best practice guidelines for using pain management devices poses a minor hurdle for the growth of the pain management devices market.

Pain Management Devices Segment Analysis:

By Type of Devices (Neuromodulation and Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices and Cryoablation Devices], and Others), Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type of devices segment, neuromodulation, and neurostimulation devices are expected to hold the largest share in the pain management devices market. The growth can be attributed to the increased prevalence of neurological disorders.

For instance, around 50 million patients are living with epilepsy worldwide, and around 2.4 million new cases are diagnosed annually, as per the data published by the Epilepsy Centre in 2020. Furthermore, According to World Health Organisation (2023) data, globally, around 50 million people have dementia, and there are nearly 10 million new cases every year. Around 60-70% of these cases are of Alzheimer's. Urgent measures to reduce this burden are therefore needed. These neurostimulators play a crucial role in treating chronic pain, Parkinson's disease, epilepsy, movement disorders, and depression. This can be due to the cost-effectiveness of neurostimulation devices, the high efficacy of transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS) devices in alleviating chronic pain, and the availability of reimbursement for SCS therapy in developed countries

Moreover, the approval of various neurostimulation devices for the treatment of chronic pain is also expected to surge segment growth.

For instance, in September 2020, Nerivio®, a smartphone-controlled electroceutical device developed by Theranica Bioelectronics for the acute treatment of episodic or chronic migraine in adolescents received CE mark approval.

Further, key market players indulge in research and development for the development of neuromodulation and neurostimulation devices for the treatment of chronic pain could also augment the market.

Recently on January 21, 2021, Saluda Medical Pty Limited announced the positive data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain.

Hence, all the aforementioned factors will contribute to the segmental growth of the pain management devices market.

North America is expected to dominate the overall Pain Management Devices Market:

North America is expected to dominate the overall pain management devices market during the forecast period. The growing prevalence of chronic pain in the region is anticipated to boost the demand for pain management devices during the forecasted period.

For instance, as per the data published in the year 2021 by the Centers for Disease Control and Prevention (CDC), it has been estimated that there will be around 78.4 million people suffering from doctor-diagnosed arthritis by 2040, and out of that two-thirds will be the women population.

As per the same source, an estimated 34.6 million adults will face arthritis-attributable activity limitations in the US by 2040. Arthritis is linked with pain in joints. There are many drug-free options for patient to consider, such as TENS, such as device TENS therapy by Omron Health.

Additionally, recent product approval and launches by the companies actively manufacturing devices for pain management will also contribute to the market growth.

For instance, in June 2021, NeuraLace announced FDA 510(k) clearance and the US Launch of Axon Therapy® Peripheral Nerve Stimulation System for chronic pain relief.

Moreover, increasing government initiatives, such as the Precision Medicine and Affordable Care Act, along with a well-planned reimbursement scenario in this region is contributing to market growth.

Thus, all the above-mentioned factors will lead to an increase in the United States pain management devices market growth during the forecasting period of 2024-2030.

Pain Management Devices Market Key Players:

Some of the key market players operating in the pain management devices market include Smiths Medical, B. Braun Melsungen AG, Baxter, Boston Scientific Corp., Colfax Corp., Medtronic Plc, Nevro Corp., Abbott, Stryker, Omron Healthcare, Inc., Stimwave LLC, and others.

Recent Developmental Activities in the Pain Management Devices Market:

In July 2022, Nevro Corp. received FDA approval for its Senza® System for the treatment of chronic pain associated with Painful Diabetic Neuropathy (PDN).

In July 2022, Unity HA received Breakthrough Device Designation by FDA for the Pulsante® SPG Microstimulator System for the treatment of acute pain associated with chronic cluster headaches.

In May 2022, SoftWave Tissue Regeneration Technologies patented extracorporeal shock wave device called the OrthGold 100® was cleared by the FDA, for the indications of a temporary increase in local blood circulation, relief of minor aches and pains, and activation of connective tissue.

Key Takes Away from the Pain Management Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global pain management devices market.

Various opportunities available for the other competitor in the pain management devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from This Pain Management Devices Market Report Study

Pain Management Devices providers

Research organizations and consulting companies

Pain Management Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders

Various End-Users who want to know more about the pain management devices market and the latest technological developments in the pain management devices market.

Frequently Asked Questions for the Pain Management Devices Market:

1. What are Pain Management Devices?

Pain management devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain, and others.

2. What is the market for global pain management devices?

The global pain management devices market was valued at USD 4.86 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 7.67 billion by 2030.

3. What are the drivers for the pain management devices market?

The major drivers driving the demand for pain management devices are the increase in the prevalence of chronic pain, the high prevalence of musculoskeletal disorders, the surge in the geriatric population, the surge in awareness among people toward pain management devices, and the growing cost of healthcare expenditure.

4. Who are the key players operating in the global pain management devices market?

Some of the key market players operating in the pain management devices market include Smiths Medical, B. Braun Melsungen AG, Baxter, Boston Scientific Corp., Colfax Corp., Medtronic Plc, Nevro Corp., Abbott, Stryker, Omron Healthcare, Inc., Stimwave LLC and others.

5. Which region has the highest share in the pain management devices market?

North America is expected to dominate the overall pain management devices market during the forecast period, 2024 to 2030. this domination is due to the growing demand for advance technologies, the increasing chronic disease in the region, and the high adoption of technological advancements owing to the rise in healthcare expenditure by the US government.

Table of Contents

1. Pain Management Devices Market Report Introduction

2. Pain Management Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Pain Management Devices Market Key Factors Analysis

  • 4.1. Pain Management Devices Market Drivers
    • 4.1.1. Rise in prevalence of chronic pain
    • 4.1.2. Surge in awareness among people toward pain management devices
    • 4.1.3. Improved R&D investment to develop innovative products
    • 4.1.4. Launch of innovative products
    • 4.1.5. Increasing cost of healthcare
  • 4.2. Pain Management Devices Market Restraints and Challenges
    • 4.2.1. Hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption
    • 4.2.2. High Cost of product
  • 4.3. Pain Management Devices Market Opportunities
    • 4.3.1. Untapped potential offered by developing economies
    • 4.3.2. Growing demand for Pain Management Devices in non-hospital settings

5. Pain Management Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Pain Management Devices Market Layout

  • 6.1. By Type of Devices
    • 6.1.1. Neuromodulation & Neurostimulation Devices
    • 6.1.2. Analgesic Infusion Pumps
      • 6.1.2.1. Intrathecal Infusion Pumps
      • 6.1.2.2. External Infusion Pumps
    • 6.1.3. Ablation Devices
      • 6.1.3.1. Radiofrequency Ablation Devices
      • 6.1.3.2. Cryoablation Devices
    • 6.1.4. Others
  • 6.2. By Application
    • 6.2.1. Neuropathic Pain
    • 6.2.2. Cancer Pain
    • 6.2.3. Facial & Migraine Pain
    • 6.2.4. Musculoskeletal Pain
    • 6.2.5. Others
  • 6.3. By Geography
    • 6.3.1. North America Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.1.1. United States Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.2. Europe Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.1. France Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.1. China Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.3. India Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia Pacific Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW) Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.4.1. Middle East Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Pain Management Devices Market Size in USD million (2021-2030)

7. Pain Management Devices Company and Product Profiles

  • 7.1. Abbott Laboratories
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Baxter International Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Boston Scientific Corporation
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. B Braun Melsungen AG
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Nevro Corp.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Colfax Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Omron Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Koninklijke Philips NV
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Smiths Medical
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medtronic plc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Stryker Corporation
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Stimwave LLC
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Kimberly Clark Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. DJO Global LLC.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Aleva neurotherapeutics SA
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Pain Management Devices Market in Global (2021-2030)
  • Table 3: Pain Management Devices Market in Global by Type of Devices (2021-2030)
  • Table 4: Pain Management Devices Market in Global by Application (2021-2030)
  • Table 5: Pain Management Devices Market in Global by Geography (2021-2030)
  • Table 6: Pain Management Devices Market in North America (2021-2030)
  • Table 7: Pain Management Devices Market in the US (2021-2030)
  • Table 8: Pain Management Devices Market in Canada (2021-2030)
  • Table 9: Pain Management Devices Market in Mexico (2021-2030)
  • Table 10: Pain Management Devices Market in Europe (2021-2030)
  • Table 11: Pain Management Devices Market in France (2021-2030)
  • Table 12: Pain Management Devices Market in Germany (2021-2030)
  • Table 13: Pain Management Devices Market in the United Kingdom (2021-2030)
  • Table 14: Pain Management Devices Market in Italy (2021-2030)
  • Table 15: Pain Management Devices Market in Spain (2021-2030)
  • Table 16: Pain Management Devices Market in Rest of Europe (2021-2030)
  • Table 17: Pain Management Devices Market in Asia-Pacific (2021-2030)
  • Table 18: Pain Management Devices Market in China (2021-2030)
  • Table 19: Pain Management Devices Market in Japan (2021-2030)
  • Table 20: Pain Management Devices Market in India (2021-2030)
  • Table 21: Pain Management Devices Market in Australia (2021-2030)
  • Table 22: Pain Management Devices Market in South Korea (2021-2030)
  • Table 23: Pain Management Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Pain Management Devices Market in the Rest of the World (2021-2030)
  • Table 25: Pain Management Devices Market in the Middle East (2021-2030)
  • Table 26: Pain Management Devices Market in Africa (2021-2030)
  • Table 27: Pain Management Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Pain Management Devices Market in Global (2021-2030)
  • Figure 3: Pain Management Devices Market in Global by Type of Devices (2021-2030)
  • Figure 4: Pain Management Devices Market in Global by Application (2021-2030)
  • Figure 5: Pain Management Devices Market in Global by Geography (2021-2030)
  • Figure 6: Pain Management Devices Market in North America (2021-2030)
  • Figure 7: Pain Management Devices Market in the US (2021-2030)
  • Figure 8: Pain Management Devices Market in Canada (2021-2030)
  • Figure 9: Pain Management Devices Market in Mexico (2021-2030)
  • Figure 10: Pain Management Devices Market in Europe (2021-2030)
  • Figure 11: Pain Management Devices Market in France (2021-2030)
  • Figure 12: Pain Management Devices Market in Germany (2021-2030)
  • Figure 13: Pain Management Devices Market in the Kingdom (2021-2030)
  • Figure 14: Pain Management Devices Market in Italy (2021-2030)
  • Figure 15: Pain Management Devices Market in Spain (2021-2030)
  • Figure 16: Pain Management Devices Market in Rest of Europe (2021-2030)
  • Figure 17: Pain Management Devices Market in Asia-Pacific (2021-2030)
  • Figure 18: Pain Management Devices Market in China (2021-2030)
  • Figure 19: Pain Management Devices Market in Japan (2021-2030)
  • Figure 20: Pain Management Devices Market in India (2021-2030)
  • Figure 21: Pain Management Devices Market in Australia (2021-2030)
  • Figure 22: Pain Management Devices Market in South Korea (2021-2030)
  • Figure 23: Pain Management Devices Market in Rest of Asia Pacific (2021-2030)
  • Figure 24: Pain Management Devices Market in the Rest of the World (2021-2030)
  • Figure 25: Pain Management Devices Market in the Middle East (2021-2030)
  • Figure 26: Pain Management Devices Market in Africa (2021-2030)
  • Figure 27: Pain Management Devices Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Market Opportunities